TITLE:
An Investigational Drug Study to Lower Non-Cholesterol Sterol Levels Associated With Sitosterolemia (0653-062)(COMPLETED)

CONDITION:
Lipid Metabolism, Inborn Errors

INTERVENTION:
MK0653, ezetimibe

SUMMARY:

      This is a 6-month study with patients who have the rare disease, sitosterolemia which may
      result in heart-related diseases. These patients have unusually high absorption of
      non-cholesterol sterols, resulting in heart-related diseases. This study investigates
      whether absorption of these non-cholesterols can be reduced in these patients.
    

DETAILED DESCRIPTION:

      The duration of treatment is 26 weeks.
    

ELIGIBILITY:
Gender: All
Age: 18 Years to 85 Years
Criteria:

        Inclusion Criteria:

          -  18 years or older, with a history of elevated sitosterol levels and have received
             treatment for at least 6 months prior to study entry.

        Exclusion Criteria:

          -  Patient has a condition which, in the opinion of the investigator, might pose a risk
             to the patient or interfere with participation in the study.
      
